I wrote my first post on opioids and workers’ comp 19 years ago. Almost two decades later, the post, which was really an excerpt from a Workers’ Comp Insider blog post by Tom Lynch and Julie Ferguson, is terrifyingly prescient:
Interesting item from Workers' Comp Insider today: There is an interesting convergence of issues concerning the pain killer OxyContin. Originally developed to combat cancer pain, OxyContin has been aggressively marketed over the past three years by its manufacturer Purdue, to the point where the drug is now the painkiller of preference for work-related injuries. This drug is twice as powerful as morphine and, while not technically addicting, it can create withdrawal symptoms when a person stops taking it. According to a study by NCCI, OxyContin is prescribed for pain in 69% of permanent partial disability cases. This same study also points out that 49% of these prescriptions go to people with back injuries. When you combine that with the next interesting piece of data — OxyContin is almost always dispensed in 50 day supplies (100 tablets) — you have a potentially volatile mix.
Kudos to Lynch and Ferguson for their early warning.
Dr. Steve Feinberg sent me a note about the Centers for Disease Control and Prevention's just-released update to opioid guidelines. There’s a lot to unpack here. A couple of key takeaways:
What does this mean for you?
Pay attention to early warning signs and don’t overreact.
Joseph Paduda is co-owner of CompPharma, a consulting firm focused on improving pharmacy programs in workers’ compensation. This column is republished with his permission from his Managed Care Matters blog.
May 5-8, 2024
Amplify Your Impact There’s no limit to what you can achieve when you join the global risk managem …
May 13-15, 2024
Join us May 13–15, 2024, for NCCI's Annual Insights Symposium (AIS) 2024, the industry’s premier e …
May 13-14, 2024
The Board of Managers is excited to announce that the CSIA 2024 Annual Meeting and Educational Con …
No Comments
Log in to post a comment